Find the latest oncology news for your sub-specialty area
A national legislative ban on life insurers discriminating against applicants based on genetic testing would…
A large, multi-layered analysis combining epidemiological, clinical, and molecular data provides strong, convergent evidence that…
A phase 2 trial, CAR-PRISM, suggests that early use of CAR T cell therapy may…
A phase 3 randomised, double-blind trial published in The Lancet has evaluated the addition of…
A phase 1b trial combining a bispecific T cell engager with a tumour-targeted costimulatory agent…
Expert guidance has been released today by a leading children and young people’s cancer charity…
In a preclinical study published in Cancer Research, a journal of the American Association for Cancer Research,…
The American Society of Haematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH)…
B-cell acute lymphoblastic leukaemia is the most common form of childhood cancer. In this type of…
For over a decade, a class of drugs called BET inhibitors has been tested in…